Oxycodon Hcl Retard Cf (Oxycodone)

Oxycodone, the active ingredient in Oxycodon Hcl Retard Cf, is an opioid analgesic presented as a controlled‑release formulation for oral use. It is employed in the management of moderate to severe pain, particularly when continuous, long‑lasting relief is required, and is prescribed for adult patients. GNH USA supplies Oxycodon Hcl Retard Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone is an opioid analgesic that acts on the central nervous system to relieve pain. It is indicated for: - Chronic cancer‑related pain: provides sustained analgesia for patients with malignant disease. - Post‑operative pain: manages moderate to severe pain following major surgery. - Severe musculoskeletal pain: alleviates persistent pain from conditions such as severe osteoarthritis or back pain when other treatments are insufficient.

Oxycodone may cause a range of adverse reactions, from mild to potentially life‑threatening.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: feeling of queasiness or urge to vomit. - Drowsiness: increased sleepiness or fatigue. - Dry mouth: reduced salivation. - Dizziness: light‑headed sensation. - Pruritus: mild itching of the skin.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be fatal. - Severe hypotension: marked drop in blood pressure. - Opioid use disorder: risk of dependence, abuse, or addiction. - Seizures: rare occurrence of convulsive episodes. - Anaphylaxis: acute allergic reaction with airway compromise. - adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing Oxycodon Hcl Retard Cf, clinicians should consider several safety measures: - Assess patient history: evaluate     ... ... ... ... ... ... ... ... ...  ...  ...  ... ... ... ... … ... ... … … … …  …  ... ... … ... ... ... … … … … … … … … … … … … ... … ... ... … … … … … … … … … … … … … … the  … … … … … … … … … … … … … … … … … … … … … … … … … … … ... … … … … ... … ... ... … ... … … … ... … …  -  … … … ... … ... … ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... … … ... … … ... … ... ... … … … ... … … … ... … … ... … ...  -  ……………  … … … … ... ... ........................…… ... … … ... ... ... … ... … …  -  -  … … … ...